144 related articles for article (PubMed ID: 31866012)
21. CtBP2 confers protection against oxidative stress through interactions with NRF1 and NRF2.
Kainoh K; Takano R; Sekiya M; Saito K; Sugasawa T; Ma Y; Murayama Y; Sugano Y; Osaki Y; Iwasaki H; Takeuchi Y; Yahagi N; Suzuki H; Miyamoto T; Nakagawa Y; Matsuzaka T; Shimano H
Biochem Biophys Res Commun; 2021 Jul; 562():146-153. PubMed ID: 34052660
[TBL] [Abstract][Full Text] [Related]
22. CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis.
Dai F; Xuan Y; Jin JJ; Yu S; Long ZW; Cai H; Liu XW; Zhou Y; Wang YN; Chen Z; Huang H
Oncotarget; 2017 Apr; 8(17):28736-28749. PubMed ID: 28404932
[TBL] [Abstract][Full Text] [Related]
23. NSM00158 Specifically Disrupts the CtBP2-p300 Interaction to Reverse CtBP2-Mediated Transrepression and Prevent the Occurrence of Nonunion.
Chen X; Zhang W; Zhang Q; Song T; Yu Z; Li Z; Duan N; Dang X
Mol Cells; 2020 Jun; 43(6):517-529. PubMed ID: 32434298
[TBL] [Abstract][Full Text] [Related]
24. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
[TBL] [Abstract][Full Text] [Related]
25. ZEB1 Represses Neural Differentiation and Cooperates with CTBP2 to Dynamically Regulate Cell Migration during Neocortex Development.
Wang H; Xiao Z; Zheng J; Wu J; Hu XL; Yang X; Shen Q
Cell Rep; 2019 May; 27(8):2335-2353.e6. PubMed ID: 31116980
[TBL] [Abstract][Full Text] [Related]
26. Assembly of human C-terminal binding protein (CtBP) into tetramers.
Bellesis AG; Jecrois AM; Hayes JA; Schiffer CA; Royer WE
J Biol Chem; 2018 Jun; 293(23):9101-9112. PubMed ID: 29700119
[TBL] [Abstract][Full Text] [Related]
27. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
28. NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
Nichols JC; Schiffer CA; Royer WE
J Biol Chem; 2021; 296():100351. PubMed ID: 33524397
[TBL] [Abstract][Full Text] [Related]
29. NADH/NAD
Erlandsen H; Jecrois AM; Nichols JC; Cole JL; Royer WE
FEBS Lett; 2022 Feb; 596(4):479-490. PubMed ID: 34997967
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
31. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
[TBL] [Abstract][Full Text] [Related]
32. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins.
Bergman LM; Morris L; Darley M; Mirnezami AH; Gunatilake SC; Blaydes JP
BMC Cell Biol; 2006 Sep; 7():35. PubMed ID: 16999872
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
Di LJ; Byun JS; Wong MM; Wakano C; Taylor T; Bilke S; Baek S; Hunter K; Yang H; Lee M; Zvosec C; Khramtsova G; Cheng F; Perou CM; Miller CR; Raab R; Olopade OI; Gardner K
Nat Commun; 2013; 4():1449. PubMed ID: 23385593
[TBL] [Abstract][Full Text] [Related]
34. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of transcriptional activation and cell proliferation activities of adenovirus E1A by the unique N-terminal domain of CtBP2.
Zhao LJ; Subramanian T; Chinnadurai G
Oncogene; 2008 Sep; 27(39):5214-22. PubMed ID: 18490918
[TBL] [Abstract][Full Text] [Related]
36. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
37. A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress.
Kang J; Gemberling M; Nakamura M; Whitby FG; Handa H; Fairbrother WG; Tantin D
Genes Dev; 2009 Jan; 23(2):208-22. PubMed ID: 19171782
[TBL] [Abstract][Full Text] [Related]
38. Obesity-induced metabolic imbalance allosterically modulates CtBP2 to inhibit PPAR-alpha transcriptional activity.
Saito K; Sekiya M; Kainoh K; Yoshino R; Hayashi A; Han SI; Araki M; Ohno H; Takeuchi Y; Tsuyuzaki T; Yamazaki D; Wanpei C; Hada L; Watanabe S; Paramita Adi Putri PI; Murayama Y; Sugano Y; Osaki Y; Iwasaki H; Yahagi N; Suzuki H; Miyamoto T; Matsuzaka T; Shimano H
J Biol Chem; 2023 Jul; 299(7):104890. PubMed ID: 37286039
[TBL] [Abstract][Full Text] [Related]
39. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
[TBL] [Abstract][Full Text] [Related]
40. POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Zhong Y; Huang H; Chen M; Huang J; Wu Q; Yan GR; Chen D
Oncotarget; 2017 Jul; 8(27):44082-44095. PubMed ID: 28489585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
